Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Revvity
Revvity To Hold Earnings Call on Monday, July 29, 2024
July 09, 2024
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity to Present at Goldman Sachs Global Healthcare Conference
May 28, 2024
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Announces Financial Results for the First Quarter of 2024
April 29, 2024
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Board Declares Quarterly Dividend
April 25, 2024
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity to Present at BofA Securities 2024 Health Care Conference
April 25, 2024
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Unveils a New Era of Automated Tuberculosis Testing
April 24, 2024
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners
April 15, 2024
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity To Hold Earnings Call on Monday, April 29, 2024
April 04, 2024
From
Revvity
Via
Business Wire
Tickers
RVTY
Preliminary Injunction Granted to Enforce Revvity’s Rights and Cloud Software Group’s Obligations Related to Spotfire Software
April 02, 2024
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Files Complaint and Seeks Injunctive Relief Against Cloud Software Group
March 20, 2024
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication
March 18, 2024
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Introduces New Workflow to Accelerate Newborn Sequencing Research
March 15, 2024
From
Revvity
Via
Business Wire
Revvity to Present at Upcoming Investor Conferences
February 21, 2024
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Signals Software Unveils Signals Clinical Solution to Accelerate Critical Clinical Trial Insights and Data-Driven Decisions
February 12, 2024
From
Revvity
Via
Business Wire
Tickers
RVTY
Propelling Diagnostics and Life Sciences Innovation from Early Phase Research to the Clinic: Revvity Showcases Cutting-Edge Solutions at SLAS2024
February 02, 2024
From
Revvity
Via
Business Wire
Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2023
February 01, 2024
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Elects Sophie Vandebroek and Michael Klobuchar to its Board of Directors
January 25, 2024
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Board Declares Quarterly Dividend
January 25, 2024
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity to Hold Earnings Call on Thursday, February 1, 2024; Provides Update on Financial Performance
January 09, 2024
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity to Present at J.P. Morgan Healthcare Conference
December 19, 2023
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Launches EONIS Q System Enabling Faster, Simplified Newborn Screening for SMA and SCID
November 27, 2023
From
Revvity
Via
Business Wire
Revvity to Present at Annual Evercore ISI HealthCONx Conference
November 14, 2023
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Announces Financial Results for the Third Quarter of 2023
October 30, 2023
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Board Declares Quarterly Dividend
October 26, 2023
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Debuts Inaugural ESG Report
October 26, 2023
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity and Element Biosciences Announce Collaboration to Improve Next Generation Sequencing Research Workflow
October 16, 2023
From
Revvity
Via
Business Wire
Revvity To Hold Earnings Call on Monday, October 30, 2023
October 09, 2023
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Expands Access to Base Editing Technology With Aim to Accelerate Discovery to Cure
September 26, 2023
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Unveils Several Next-Generation Preclinical Imaging Technologies to Help Scientists Drive Breakthrough Discoveries
September 05, 2023
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity to Present at Upcoming September Investor Conferences
August 23, 2023
From
Revvity
Via
Business Wire
Tickers
RVTY
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.